Treating Children with Cancer | FDA Voice
Treating Children with Cancer
The conversation is between Robert “Skip” Nelson, M.D., Ph.D., deputy director and senior pediatric ethicist in FDA’s Office of Pediatric Therapeutics, and Gregory Reaman, M.D., associate director of the Office of Hematology and Oncology Products.
It begins with a discussion of FDA’s role in evaluating medications used to treat children with cancer and what measures are underway to encourage further development of these important drugs.
For More Information
Pediatrics
New Pediatric Labeling Information Database
Cancer Liaison Program
Office of Hematology and Oncology Products
No hay comentarios:
Publicar un comentario